InvestorNewsBreaks

Friday Jun 20, 2025 - 3:43 pm

InvestorNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Leveraging MCO Success to Elevate Portfolio Clubs to the International Stage

Brera Holdings (NASDAQ: BREA), an Ireland-based company focused on expanding a global portfolio of men’s and women’s sports clubs, is successfully leveraging its multi-club ownership (“MCO”) approach, remaining bullish about S.S. Juve Stabia and its other portfolio clubs worldwide. “Brera is the first publicly traded MCO group through its Nasdaq IPO and continues to make waves in the industry. By providing a differentiated structure that…

Friday Jun 20, 2025 - 3:30 pm

InvestorNewsBreaks – Why Silvercorp Metals Inc. (NYSE American: SVM) (TSX: SVM) Is ‘One to Watch’

Silvercorp Metals (NYSE American: SVM) (TSX: SVM) is a Canadian mining company with a strong track record of profitability, managing a broad portfolio of producing mines, development-stage projects, and exploration assets across China, Ecuador, and Bolivia. The company is committed to maximizing output from its existing operations while strategically advancing new projects to support long-term growth. As noted in a recent article, Silvercorp’s diversified asset…

Friday Jun 20, 2025 - 10:33 am

InvestorNewsBreaks – Nicola Mining Inc. (TSX.V: NIM) (FSE: HLIA) (OTCQB: HUSIF) Begins AI-Enhanced Drill Program at New Craigmont Copper Project

Nicola Mining (TSX.V: NIM) (FSE: HLIA) (OTCQB: HUSIF) has launched its 2025 diamond drilling campaign at the New Craigmont Copper Project near Merritt, British Columbia. The program targets 4,000–5,000 meters of drilling across five priority zones, including two new AI-generated targets identified in partnership with ALS Geoanalytics (GoldSpot Discoveries Ltd.). The focus is to delineate porphyry-style copper mineralization and advance exploration around key zones like…

Friday Jun 20, 2025 - 9:30 am

InvestorNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Earns FDA Clearance for First Cable-Free ECG System for Arrhythmia Detection

HeartBeam (NASDAQ: BEAT) announced it has received FDA 510(k) clearance for its flagship ECG system, a first-of-its-kind, credit card-sized, cable-free device designed to deliver high-fidelity, three-directional cardiac recordings for arrhythmia evaluation. The clearance marks a major regulatory milestone and accelerates HeartBeam’s plans to improve access to timely, remote cardiac care. When symptoms arise, patients use the app-guided system to record a 30-second ECG, which is…

Friday Jun 20, 2025 - 9:25 am

InvestorNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Gains 18-Month NYSE Compliance Window

Annovis Bio (NYSE: ANVS), a clinical-stage platform company developing therapies for neurodegenerative diseases including Alzheimer’s and Parkinson’s, has received formal acceptance from the New York Stock Exchange of its compliance plan addressing minimum market capitalization and stockholders’ equity requirements. The NYSE granted the company an 18-month window, beginning March 26, 2025, to regain compliance. During this period, Annovis Bio will continue trading on the NYSE,…

Friday Jun 20, 2025 - 9:00 am

InvestorNewsBreaks – Sekur Private Data Ltd. (CSE: SKUR) (OTCQX: SWISF) (FSE: GDT0) Launches CA$2 Million Private Placement to Accelerate Global Marketing Push

Sekur Private Data (CSE: SKUR) (OTCQB: SWISF) (FSE: GDT0) a Swiss-based cybersecurity and privacy communications company, has launched a non-brokered private placement to raise up to CA$2 million (US$1.4 million). The offering consists of up to 40 billion units priced at CA$0.05 per unit, with each unit comprising one common share and one full share purchase warrant. Each warrant allows the holder to buy one…

Wednesday Jun 18, 2025 - 2:40 pm

InvestorNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Signs MOU to Advance Quantum Computing in South Korea

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, announced that it has signed a memorandum of understanding (MOU) with Yonsei University and Incheon Metropolitan City aimed at accelerating quantum computing adoption in South Korea. Supporting the region’s ambition to become a global quantum technology hub, the MOU outlines plans to work together on research, talent development, and use case…

Wednesday Jun 18, 2025 - 2:18 pm

InvestorNewsBreaks – Authentic Holdings (OTC: AHRO) Subsidiary Maybacks Global Launches Hit Broadcast of Ring of Combat via Swerve TV

Authentic Holdings (OTC: AHRO) announced a major licensing agreement between its subsidiary Maybacks Global Entertainment, LLC and Swerve TV, marked by a successful debut broadcast of "Ring of Combat" from the Tropicana in Atlantic City on June 13. The event exceeded expectations, drawing substantial viewership and social media traction across Swerve TV's extensive platform, which reaches 80% of U.S. and Canadian households and over 5…

Wednesday Jun 18, 2025 - 1:49 pm

InvestorNewsBreaks – Aegis Capital Corp. Announces Completion of $4.3 Million Public Offering for Stardust Power (NASDAQ: SDST)

Aegis Capital, acting as sole book-running manager, today announced the successful closing of a $4.3 million underwritten public offering for Stardust Power Inc. (NASDAQ: SDST), an American developer of battery-grade lithium products. The offering included 21,500,000 shares of common stock at a public offering price of $0.20 per share. Stardust Power has also granted Aegis a 45-day option to purchase up to an additional 3,225,000…

Wednesday Jun 18, 2025 - 12:02 pm

InvestorNewsBreaks – Telomir Pharmaceuticals (NASDAQ: TELO) Reports Preclinical Success for Telomir-1 in Progeria Cell Lines

Telomir Pharmaceuticals (NASDAQ: TELO) announced new preclinical data demonstrating that its lead candidate, Telomir-1, prevented cellular aging in human progeria cell lines obtained from the Progeria Research Foundation. In studies conducted by Smart Assays, Telomir-1 improved cell viability, reduced oxidative stress, and restored mitochondrial function in cells from a child with Hutchinson-Gilford Progeria Syndrome (HGPS), an ultra-rare pediatric aging disorder. Unlike the only FDA-approved treatment,…

Wednesday Jun 18, 2025 - 11:45 am

InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Advances Brain and Alcohol Health Pipeline, Receives Phase 2 Trial Approval for FSD202

Quantum BioPharma (NASDAQ: QNTM) continues to advance its pipeline targeting brain disorders and alcohol health, with Singular Research highlighting new clinical milestones and strategic updates. The company secured human ethics approval for a Phase 2 trial of FSD202 in patients with Idiopathic Mast Cell Activation Syndrome, marking progress in addressing unmet needs in inflammatory pain. Meanwhile, Quantum is preparing an IND filing for its Lucid-MS compound…

Wednesday Jun 18, 2025 - 10:45 am

InvestorNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) to Deploy Fingerprint Drug Testing System Across MWS Sites in Australia

Intelligent Bio Solutions (NASDAQ: INBS) announced that Managed Waste Service (MWS), a leading Australian waste management provider, will implement INBS’ Intelligent Fingerprinting Drug Screening System across its New South Wales operations. Covering over 20 remote land clearing and green waste sites, this marks MWS’s first shift to in-house, on-site drug testing for pre-employment, random, and for-cause purposes. The fingerprint-based system delivers non-invasive results in under…

Wednesday Jun 18, 2025 - 10:00 am

InvestorNewsBreaks – Psyence Biomedical Ltd. (NASDAQ: PBM) to Present at Psychedelic Science 2025

Psyence Biomed (NASDAQ: PBM) has announced that its Chief of Global Impact, Mary-Elizabeth Gifford, was selected as a featured speaker at Psychedelic Science 2025 (“PS2025”) – the world's largest international gathering focused on psychedelic research, biopharma, medicine, policy, and culture. Hosted by the Multidisciplinary Association for Psychedelic Studies (“MAPS”), the highly anticipated conference is taking place June 16-20, 2025, in Denver, Colorado. Psyence BioMed will…

Wednesday Jun 18, 2025 - 9:20 am

InvestorNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Advances Aversa Fentanyl with Kindeva to Commercial Manufacturing Scale

Nutriband (NASDAQ: NTRB), a developer of prescription transdermal pharmaceutical products, announced the successful commercial manufacturing process scale-up of its lead product, Aversa™ Fentanyl, in collaboration with Kindeva, a global CDMO specializing in drug-device combinations. Aversa Fentanyl integrates Nutriband’s AVERSA™ abuse-deterrent technology with Kindeva’s FDA-approved fentanyl patch and is produced at Kindeva’s U.S.-based transdermal facility. The next step involves producing clinical supplies and submitting an Investigational…

Wednesday Jun 18, 2025 - 9:10 am

InvestorNewsBreaks – Red Cat Holdings Inc. (NASDAQ: RCAT) Announces $46.75M Registered Direct

Red Cat Holdings (NASDAQ: RCAT), a drone technology company integrating robotic hardware and software for military, government, and commercial operations, has announced its entry into securities purchase agreements with certain institutional investors for the purchase and sale of 6,448,276 shares of common stock, pursuant to a registered direct offering. The company anticipates gross proceeds of approximately $46.75 million from the offering, which, subject to the…

Wednesday Jun 18, 2025 - 9:10 am

InvestorNewsBreaks – GivBux Inc. (OTC: GBUX) Finalizes Deal to Acquire Charter House, Refocuses on Gold-Backed Fintech Expansion

GivBux (OTC: GBUX), a publicly traded Super App and charitable giving platform, announced it has finalized a Share Exchange Agreement to acquire 100% of Charter House Financial AU, with the transaction set to close by July 13, 2025. The acquisition marks a shift in GivBux's strategic focus toward gold-backed financial services, leveraging Charter House’s asset-backed infrastructure and global networks. The companies plan to integrate operations…

Wednesday Jun 18, 2025 - 9:00 am

InvestorNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Secures Two New Patents Advancing 3D ECG and Cardiac Monitoring Technology

HeartBeam (NASDAQ: BEAT), announced the issuance of two new U.S. patents that strengthen its intellectual property portfolio and support the company’s expansion in remote cardiac diagnostics. The new patents protect core technologies behind HeartBeam’s compact, cable-free 3D ECG device and its rhythm analysis algorithm capable of identifying arrhythmias through continuous signal input. The 3D ECG device, which uses chest and finger electrodes to collect high-fidelity…

Wednesday Jun 18, 2025 - 9:00 am

InvestorNewsBreaks – NanoViricides (NYSE American: NNVC) Highlights NV-387 as Broad-Spectrum Antiviral Candidate for COVID and Bird Flu Preparedness

NanoViricides, Inc. (NYSE American: NNVC) asserts that its antiviral candidate NV-387 is uniquely positioned to address rising global threats from emerging COVID-19 variants like NB1.8.1 “Nimbus” and evolving strains of Bird Flu, including highly pathogenic genotypes identified in the U.S. and Cambodia. NV-387, which has completed Phase I trials without adverse events, is designed as an oral, broad-spectrum antiviral that mimics heparan sulfate structures—an invariant…

Wednesday Jun 18, 2025 - 9:00 am

InvestorNewsBreaks – Newton Golf Company Inc. (NASDAQ: NWTG) Signs Miguel Ángel Jiménez Following Victory with Fast Motion Shaft

Newton Golf Company (NASDAQ: NWTG), a technology-forward golf brand, announced that PGA TOUR Champions star Miguel Ángel Jiménez has officially joined the company and will play its Newton Fast Motion shaft, which he used to win the Principal Charity Classic. Jiménez’s playoff win in Iowa marked his 16th PGA TOUR Champions title and the second Tour victory for Newton’s Motion shaft line. The Fast Motion…

Tuesday Jun 17, 2025 - 1:14 pm

InvestorNewsBreaks – BluSky AI Inc. (OTC: BSAI) to Upgrade to OTCID Tier on July 1, Signaling Stronger Market Position

BluSky AI (OTC: BSAI) announced it will transition from the OTC Pink Sheets to the OTCID tier effective July 1, 2025, reflecting its enhanced reporting, compliance, and transparency standards. The move marks a milestone in the company’s strategic growth, following recent achievements including modular AI datacenter expansion, new infrastructure partnerships, a GPU-as-a-Service launch, and improved financial governance. CEO Trent D’Ambrosio stated the upgrade underscores BluSky…

Tuesday Jun 17, 2025 - 10:21 am

InvestorNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Launches Biofuel Crop Optimization Project with Brookhaven Lab

Datavault AI (NASDAQ: DVLT) is spearheading the development of an AI-driven multi-modal machine learning system to accelerate biofuel crop optimization, targeting increased fatty acid metabolism in canola (Brassica napus). In collaboration with the U.S. Department of Energy’s Brookhaven National Laboratory, the project applies high-performance computing and digital twin technology to model metabolic pathways and reduce the development time for commercially viable biofuel crops. With U.S.…

Tuesday Jun 17, 2025 - 9:20 am

InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Begins First MS Patient Scan in MGH PET Imaging Study

Quantum BioPharma (NASDAQ: QNTM) has announced that the first multiple sclerosis patient has been scanned in a collaborative study with Massachusetts General Hospital to validate a novel PET imaging technique for tracking myelin integrity. The study uses the tracer [18F]3F4AP, developed by MGH’s Dr. Pedro Brugarolas, which has shown high sensitivity to demyelinated lesions. Scanning took place on a new GE Signa PET-MR scanner, enabling simultaneous…

Tuesday Jun 17, 2025 - 9:15 am

InvestorNewsBreaks – ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Launches $3.3 Million Private Placement to Advance Montauban Project

ESGold (CSE: ESAU) (OTCQB: ESAUF) announced a non-brokered private placement of units priced at $0.73 each, targeting gross proceeds of up to $3.285 million. Each unit comprises one common share and one share purchase warrant, exercisable at $0.91 for 18 months. The initial closing is scheduled for June 20, 2025, with additional tranches possible. Proceeds will support mill circuit construction, final mobilization at the Montauban…

Tuesday Jun 17, 2025 - 9:10 am

InvestorNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) CEO Highlights Fingerprint Drug Testing on BioMedWire Podcast

Intelligent Bio Solutions (NASDAQ: INBS) CEO Harry Simeonidis joined the latest episode of The BioMedWire Podcast to discuss the company’s rapid, non-invasive drug screening platform and global expansion strategy. Simeonidis detailed how the company’s fingerprint-based technology detects drug use through sweat, enabling faster and more affordable workplace screening. With current deployments in about 20 countries and an FDA application under review, Intelligent Bio Solutions is…

Tuesday Jun 17, 2025 - 9:00 am

InvestorNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) and AccurKardia Join Forces to Advance Remote Cardiac Monitoring

HeartBeam to integrate AccurECG(TM), AccurKardia’s FDA-cleared ECG analysis software Collaboration enhances HeartBeam’s commercial offering with automated arrhythmia insights Combined platform aims to improve cardiac care access and speed time to diagnosis HeartBeam (NASDAQ: BEAT) announced a strategic collaboration with AccurKardia, a leader in automated ECG diagnostics, to integrate its FDA-cleared AccurECG(TM) software into HeartBeam’s cable-free, credit card-sized 3D ECG device. The partnership unites two innovators…

Tuesday Jun 17, 2025 - 9:00 am

InvestorNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) Partners with Qingling Motors to Develop Intelligent Commercial Vehicle Solutions

FingerMotion (NASDAQ: FNGR) announced that its subsidiary, JiuGe Technology, is collaborating with Qingling Motors to co-develop intelligent vehicle solutions aimed at improving efficiency and sustainability in commercial mobility. The partnership targets high-demand sectors like logistics and emergency response, with Qingling leading vehicle design and compliance while JiuGe contributes software integration and smart system development. A joint technical taskforce has been formed to accelerate innovation, share…

Tuesday Jun 17, 2025 - 9:00 am

InvestorNewsBreaks – Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT) Secures $4.5 Million and Extends National Marketing Campaign

Foremost Clean Energy (NASDAQ: FMST) (CSE: FAT) announced a strengthened financial position with over $4.5 million raised through recent warrant and option exercises by insiders and investors. The added capital supports ongoing exploration and drilling initiatives amid rising uranium prices and a forecasted structural supply deficit. Concurrently, the company is extending its strategic investor awareness campaign with LFG Equities Corp., aimed at highlighting Foremost’s unique…

Monday Jun 16, 2025 - 2:00 pm

InvestorNewsBreaks – ROTH’s 15th Annual London Conference to Showcase Market Trends, Compelling Investment Opportunities

Roth Capital Partners (“ROTH”), www.roth.com, today announced the agenda and details for its 15th Annual London Conference, which is slated to take place at the Four Seasons Hotel at Park Lane in London on June 24-26, 2025. The event is designed to foster meaningful dialogue between institutional investors and C-suite leaders and senior executives from approximately 80 companies with a strong focus on the sustainability…

Monday Jun 16, 2025 - 10:10 am

InvestorNewsBreaks – Lantern Pharma Inc. (NASDAQ: LTRN) Reports Complete Response in Advanced NSCLC Patient in HARMONIC(TM) Trial

Lantern Pharma (NASDAQ: LTRN) announced a remarkable clinical outcome in its Phase 2 HARMONIC(TM) trial, with a 70-year-old never-smoker with advanced non-small cell lung cancer (NSCLC) achieving a durable complete response following treatment with LP-300 in combination with standard chemotherapy. The patient, who had previously failed three lines of therapy including Keytruda(R), radiation, and Tagrisso(R), initially saw a 57% tumor reduction and later achieved full resolution…

Monday Jun 16, 2025 - 9:20 am

InvestorNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Forms Investor Relations Partnership With astr Partners

NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, and its subsidiary HOPE Therapeutics announced a strategic investor relations partnership with astr partners, a boutique firm specializing in life sciences. The collaboration comes as NRx advances toward two NDA filings, an ANDA submission, and expands its interventional psychiatry clinic acquisitions. Led by veterans of The Trout Group, astr will support NRx and HOPE with investor targeting,…

Monday Jun 16, 2025 - 9:10 am

InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Presents Positive Phase 3 Data on Fibromyalgia Drug at EULAR 2025

Tonix Pharmaceuticals (NASDAQ: TNXP) presented new data at the 2025 Annual European Congress of Rheumatology (EULAR) in Barcelona supporting TNX-102 SL, its sublingual cyclobenzaprine formulation for fibromyalgia. The poster highlighted results from the RESILIENT Phase 3 trial showing statistically significant, sustained pain reduction over 14 weeks, along with improved sleep and favorable tolerability. Designed to bypass first-pass liver metabolism, TNX-102 SL achieved higher nighttime cyclobenzaprine…

Monday Jun 16, 2025 - 9:05 am

InvestorNewsBreaks – SolarBank Corporation (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Advances 2.4 MW Community Solar Project in Nova Scotia

SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) announced progress on its 2.4 MW DC Sydney project in Nova Scotia, reinforcing its expansion in the Canadian community solar market. Valued at $4.57 million and developed in partnership with AI Renewable Flow-through Fund and Trimac Engineering, the project is expected to produce 2,730 MWh of clean energy annually—enough to power 221 homes and offset 1,900 tons…

Monday Jun 16, 2025 - 9:00 am

InvestorNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) VALID-ECG Study Confirms Diagnostic Accuracy of Synthesized 12-Lead ECG

HeartBeam’s credit card-sized device demonstrated 93.4% diagnostic agreement with standard ECGs VALID-ECG study results presented at Heart Rhythm Society conference Company eyes U.S. commercialization pending FDA clearance HeartBeam (NASDAQ: BEAT) announced its synthesized 12-lead ECG met clinical endpoints in the VALID-ECG pivotal study, achieving 93.4% diagnostic agreement with standard ECGs for arrhythmia assessment. The findings, presented by Dr. Thomas Deering of Piedmont Heart Institute at…

Friday Jun 13, 2025 - 3:41 pm

InvestorNewsBreaks – SolarBank Corp.’s (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Forest Hill Rd Project Adds to Growing Development Pipeline

Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) was featured in a recent article that discussed its momentum with the development of its Forest Hill Rd solar project in upstate New York. “The 4.584 megawatt DC installation will operate as a community solar facility, contributing renewable energy to the local grid and offering cost savings to approximately 540 homes,”…

Friday Jun 13, 2025 - 2:49 pm

InvestorNewsBreaks – Driving the Future of Powersports: Massimo Group’s (NASDAQ: MAMO) Bold Strategy for Market Growth

As the powersports and recreational watercraft industries experience a notable upswing, Massimo Group (NASDAQ: MAMO) is taking a proactive approach through domestic manufacturing, strategic partnerships, and product diversification—initiatives that position the company to capitalize on emerging opportunities. Fueled by growing consumer enthusiasm for outdoor recreation and the multi-purpose appeal of vehicles like those in Massimo’s lineup, the global powersports market—valued at $37.96 billion in 2023—is…

Friday Jun 13, 2025 - 2:36 pm

InvestorNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Reported Q1 2025 Results, Advanced Toward Commercialization Following VALID-ECG Study Success

HeartBeam (NASDAQ: BEAT) reported financial results and operational highlights for the first quarter of 2025, marking significant progress toward commercialization of its 12-lead ECG synthesis software. The company successfully met clinical endpoints in its VALID-ECG pivotal study, demonstrating a 93.4% diagnostic agreement with standard ECGs, and engaged in productive discussions with the FDA on its 510(k) submission. During the quarter, HeartBeam entered a strategic collaboration…

Friday Jun 13, 2025 - 2:10 pm

InvestorNewsBreaks – Why Beeline Holdings Inc. (NASDAQ: BLNE) Is ‘One to Watch’

Beeline Holdings (NASDAQ: BLNE) is a technology-forward mortgage and title platform leveraging AI, automation, and intuitive user experiences to simplify home financing. “Through wholly owned subsidiary Beeline Loans Inc., the company delivers fast and flexible loan solutions for both primary homebuyers and real estate investors. Beeline has built an end-to-end digital lending ecosystem designed to eliminate friction, reduce costs, and dramatically shorten closing timelines,” reads…

Friday Jun 13, 2025 - 10:55 am

InvestorNewsBreaks – RedCloud Holdings plc (NASDAQ: RCT) to Participate in ROTH 15th Annual London Conference

RedCloud Holdings (NASDAQ: RCT) announced that CEO and Co-Founder Justin Floyd will attend the ROTH 15th Annual London Conference, taking place at the Four Seasons Hotel London at Park Lane. The event provides a platform for RedCloud to engage with investors and industry stakeholders in an international setting. To view the full press release, visit https://ibn.fm/VPEqF About RedCloud RedCloud has developed and operates the RedCloud trading…

Friday Jun 13, 2025 - 9:15 am

InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Plans Special Dividend Linked to Litigation Proceeds

Quantum BioPharma (NASDAQ: QNTM) announced plans to issue a special dividend in the form of Contingent Value Rights (“CVRs”) to holders of its Class B Subordinate Voting Shares on a 1:1 basis. The CVRs will entitle shareholders to a pro rata share of between 10% and 50% of any net proceeds recovered from the company’s pending $700 million+ litigation against several banks over alleged stock manipulation.…

Friday Jun 13, 2025 - 9:10 am

InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Highlights Progress on Phase 3 Psychedelic Therapeutics Program

Cybin (NYSE American: CYBN) (NEO: CYBN) issued a corporate update emphasizing continued momentum in its clinical pipeline, including the advancement of its lead candidate CYB003 into Phase 3 development. CEO Doug Drysdale underscored the growing regulatory clarity around psychedelic therapeutics and expressed optimism that Cybin’s IP portfolio and clinical strategy position the company to help transform mental health treatment. Drysdale also noted favorable shifts in…

InvestorNewsBreaks

Get Started with InvestorWire

Press Distribution

Explore Press Distribution Solutions

Discover Add-on Solutions